Residual risk of bacterial contamination of platelets: six years of experience with sterility testing

Transfusion

Volumn 57, Issue 9, 2017, Pages 2174-2181

  Ramirez Arcos, Sandra ^a   DiFranco, Caesar ^a   McIntyre, Terri ^a   Goldman, Mindy ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

ANAEROBIC BACTERIUM; APHERESIS; ARTICLE; BACTERIUM CONTAMINATION; BLOOD AUTOTRANSFUSION; BLOOD BANK; BLOOD TRANSFUSION REACTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; FALSE POSITIVE RESULT; FERTILITY; HUMAN; QUALITY CONTROL; RISK FACTOR; SEPSIS; STAPHYLOCOCCUS AUREUS; THROMBOCYTE; BLOOD SAFETY; BLOOD STORAGE; CANADA; FALSE NEGATIVE RESULT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFECTION CONTROL; INSTRUMENT STERILIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES; STANDARDS; STAPHYLOCOCCUS INFECTION;

BACTERIOLOGICAL TECHNIQUES; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD SAFETY; CANADA; FALSE NEGATIVE REACTIONS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFECTION CONTROL; QUALITY CONTROL; STAPHYLOCOCCAL INFECTIONS; STERILIZATION;

EID: 85021339267     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14202     Document Type: Article

References (45)

1. US Food and Drug Administration (FDA). Fatalities reported to FDA following blood collection and transfusion. Annual summary for Fiscal Year 2015 [cited 2017 Jan 11]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM518148.pdf.
2. Hong H, Xiao W, Lazarus HM, Good CE, Maitta RW, Jacobs MR. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance. Blood 2016;127:496-02.
3. de Korte D, Marcelis JH. Platelet concentrates: reducing the risk of transfusion-transmitted bacterial infections. Int J Clin Transfus Med 2014;2:24-37.
4. Ramirez-Arcos S, Goldman M. Bacterial contamination. In: Popovsky MA, editor, Transfusion reactions. Bethesda (MD): American Association of Blood Banks; 2012. p. 153-81.
5. Pietersz RN, Reesink HW, Panzer S, et al. Bacterial contamination in platelet concentrates. Vox Sang 2014;106:256-83.
6. Kou Y, Pagotto F, Hannach B, Ramírez-Arcos S. Fatal false-negative transfusion infection involving a buffy coat platelet pool contaminated with biofilm-positive Staphylococcus epidermidis: a case report. Transfusion 2015;55:2384-9.
7. Vollmer T, Kleesiek K, Dreier J. Detection of bacterial contamination in platelet concentrates using flow cytometry and real-time PCR methods. Methods Mol Biol 2013;943:91-103.
8. Harm SK, Delaney M, Charapata M, Aubuchon JP, Truilzi DJ, Yazer MH. Routine use of a rapid test to detect bacteria at the time of issue for nonleukoreduced, whole blood-derived platelets. Transfusion 2013;53:843-50.
9. Heaton WA, Good CE, Galloway-Haskins R, Yomtovian RA, Jacobs MR. Evaluation of a rapid colorimetric assay for detection of bacterial contamination in apheresis and pooled random-donor platelet units. Transfusion 2014;54:1634-41.
10. Ramírez-Arcos S, Jenkins C, Dion J, Bernier F, Delage G, Goldman M. Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007;47:421-9.
11. McDonald C, Allen J, Brailsford S, et al. Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure. Transfusion 2017;57:1122–31.
12. Mastronardi C, Perkins H, Derksen P, den Admirant M, Ramírez-Arcos S. Evaluation of the BacT/ALERT 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services. Clin Chem Lab Med 2010;48:1179-87.
13. Levin E, Culibrk B, Gyöngyössy-Issa MI, et al. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Transfusion 2008;48:2331-7.
14. Jenkins C, Ramírez-Arcos S, Goldman M, Devine DV. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011;51:2555-65.
15. Eder AF, Kennedy JM, Dy BA, et al. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion 2009;49:1554-63.
16. Benjamin RJ, Dy B, Perez J, Eder AF, Wagner SJ. Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results. Vox Sang 2014;106:23-30.
17. AABB. AABB Association Bulletin 04-07 [cited 2017 Jan 09]. Available from: http://www.aabb.org/programs/publications/bulletins/Pages/ab04-07.aspx.
18. Canadian Standards Association (CSA). CSA Standard-Z902-15-blood and blood components. Mississauga (ON): Canadian Standards Association; 2015.
19. Benjamin RJ, Wagner SJ. The residual risk of sepsis: modelling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates. Transfusion 2007;47:1381-9.
20. Pearce S, Rowe GP, Field SP. Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med 2011;21:25-32.
21. Dumont LJ, Kleinman S, Murphy JR, et al. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010;50:589-99.
22. Blajchman MA, Beckers EA, Dickmeiss E, Lin L, Moore G, Luylle L. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev 2005;19:259-72.
23. Larsen CP, Ezligini F, Hermansen NO, Kjeldsen-Kragh J. Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005;88:93-7.
24. Murphy WG, Foley M, Doherty C, et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008;95:13-9.
25. Ramírez-Arcos S, Kou Y, Mastronardi C, Perkins H, Goldman M. Bacterial screening of outdated buffy coat platelet pools using a culture system and a rapid immunoassay. Transfusion 2011;51:2566-72.
26. Paglia G, Sigurjónsson ÓE, Rolfsson Ó, et al. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates. Transfusion 2015; 55:301-13.
27. Taha M, Kalab M, Yi QL, et al. Bacterial survival and distribution during buffy coat platelet production. Vox Sang 2016;111:333-40.
28. Störmer M, Kleesiek K, Dreier J. Propionibacterium acnes lacks the capability to proliferate in platelet concentrates. Vox Sang 2008;94:193-01.
29. Ali H, Rood IG, de Korte D, Ramírez-Acros S. Strict anaerobic Staphylococcus saccharolyticus isolates recovered from contaminated platelet concentrates fail to multiply during platelet storage. Transfusion 2012;52:916-7.
30. Schneider T, Brevière D, Taillefer MF, Pujol-Rey A, Huart JJ. Bacterial contamination of platelet concentrates by Propionibacterium acnes [article in French]. Transfus Clin Biol 2000;7:540-6.
31. McDonald CP, Hartley S, Orchard K, et al. Fatal Clostridium perfringens sepsis from a pooled platelet transfusion. Transfus Med 1998;8:19-22.
32. Eder AF, Meena-Leist CE, Hapip CA, Dy BA, Benjamin RJ, Wagner SJ. Clostridium perfringens in apheresis platelets: an unusual contaminant underscores the importance of clinical vigilance for septic transfusion reactions (CME). Transfusion 2014;54:857-62.
33. US Food and Drug Administration (FDA). Fatalities reported to FDA following blood collection and transfusion. Annual summary for Fiscal Year 2010. [cited 2017 Jan 09]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM254860.pdf.
34. Rowlinson M-C, LeBourgeois P, Ward K, Song Y, Finegold Sm, Bruckner DA. Isolation of a strictly anaerobic strain of Staphylococcus epidermidis. J Clin Microbiol 2006;44:857-60.
35. Kamel H, Bravo MD, Townseed M, et al. Yield of proportionate ≥3.8% sample volume of mother bag on bacterial contamination detection in Trima apheresis platelet collections. Transfusion 2015;55:181A.
36. Brecher ME, Hay SN. Platelet senescent cultures and the predictive value of an early culture [letter]. Transfusion 2006;46:311-2.
37. Su LL, Kamel HT, Custer B, et al. Bacterial detection in apheresis platelets: blood systems experience with a two-bottle and one-bottle culture system. Transfusion 2010;48:1842-52.
38. Corvino T, Strauss D, Lessig M. Evaluation of the elimination of the anaerobic bottle in the testing of plateletpheresis in a blood center. Abstract SP466. Transfusion 2009;49s:227A.
39. Greco-Stewart VS, Brown EE, Parr C, et al. Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture. Vox Sang 2012;102:212-20.
40. Jacobs MR, Good CE, Lazarus HM, Yomtovian RA. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008;46:1214-20.
41. Loza-Correa M, Kou Y, Taha M, et al. Septic transfusion case caused by a platelet pool with visible clotting due to contamination with Staphylococcus aureus. Transfusion 2017;57:1299-303.
42. Delage G, Bernier F, Beaudoin J, Thibault S, Dion J, Gagne L. Improved bacterial culture of platelet product: preliminary results after implementation of a two-bottle system with 48-hour sampling. Abstract S62-030I. Transfusion 2016;56(S4):28A.
43. Vollmer T, Schottstedt V, Bux J, Walther-Wenke G, Knabbe C, Dreier J. Bacterial screening of platelet concentrates on day 2 and 3 with flow cytometry: the optimal sampling time point? Blood Transfus 2014;12:388-95.
44. Amsler L, Jutzi M. Swissmedic haemovigilance annual report 2015 [cited 2017 Jan 10]. Available from: https://www.swissmedic.ch/suchen/index.html?q=intercept&lang=en&search=.
45. US Food and Drug Administration (FDA). Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion [cited 2017 Apr 4]. Available at: https://www.fda.gov/downloads/Guidances/Blood/UCM425952.pdf.